Vnitr Lek 2008, 54(10):945-947

Nukleární kardiologie: postradatelná, či nepostradatelná? - editorial

J. Veselka
Kardiologické oddělení, Kardiovaskulární centrum 1. lékařské fakulty UK a FN Motol, primář prof. MUDr. Josef Veselka, CSc., FESC, FSCAI, FICA

Received: May 28, 2008; Published: October 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Veselka J. Nukleární kardiologie: postradatelná, či nepostradatelná? - editorial. Vnitr Lek. 2008;54(10):945-947.
Download citation

References

  1. Kamínek M, Hutyra M. Zobrazovací metody v diagnostice viability myokardu. Část 1. Interpretace nálezů při zobrazení viability myokardu pomocí SPECT a PET. Vnitř Lék 2008; 54: 971-978. Go to PubMed...
  2. Clark AN, Beller GA. The present role of nuclear cardiology in clinical practice. Q J Nucl Med Imaging 2005; 49: 43-58.
  3. Meluzín J, Černý J, Groch L et al. Prognostic importance of quantification of myocardial viability in revascularized patients with coronary artery disease and moderate-to-severe left ventricular dysfunction. Int J Cardiol 2003; 90: 23-31. Go to original source... Go to PubMed...
  4. Bateman TM, Prvulovich E. Assessment of prognosis in chronic coronary artery disease. Heart 2004; 90 (Suppl 5): 10-15. Go to original source... Go to PubMed...
  5. Hachamovitch R, Gates S, Friedman J et al. Determinants of risk and its temporal variation in patiens with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003; 41: 1329-1340. Go to original source... Go to PubMed...
  6. Pijls NH. Is it time to measure fractional flow reserve in all patients? J Am Coll Cardiol 2003; 41: 1122-1124. Go to original source... Go to PubMed...
  7. Vesely MR, Dilsizian V. Nuclear cardiac stress testing in the era of molecular medicine. J Nucl Med 2008; 49: 399-413. Go to original source... Go to PubMed...
  8. Metelková I, Kamínek J, Budíková M et al. Senzitivita a specificita zátěžového gated SPECT-zobrazení myokardu pro detekci ischemické choroby srdeční: validace nálezů pomocí koronarografie. Cor Vasa 2008; 50: 191-194. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.